inhaled gm-csf
Phase 3- Indications
- Pulmonary alveolar proteinosis, Acute respiratory distress syndrome
Company intelligence / Profile preview
Serendex Pharmaceuticals
Hørsholm/Copenhagen area, Capital Region of Denmark/Hovedstaden, Denmarkserendex.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Serendex developed a pipeline of inhaled therapies for rare and severe respiratory diseases. Its most advanced asset was Molgradex®—inhaled molgramostim—for autoimmune pulmonary alveolar proteinosis, which reached Phase II/III clinical trials. The company pursued drug repositioning strategies with orphan drug designations to accelerate development timelines. In July 2016, it was acquired by Savara Pharmaceuticals.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Inhaled biologics (notably GM-CSF/molgramostim and Factor VIIa)Repositioned small molecules (e.g., fosfomycin)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
CMC Biologics for manufacturing support of Factor VIIa programVarious pharma/drug development collaborations globally
Beyond the preview
Go deeper on Serendex Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serendex Pharmaceuticals.